Form 4: Edwards Lifesciences Executive Reports Stock Disposal to Cover Tax Obligations
SEC Filing
Daniel J. Lippis, CVP of JAPAC at Edwards Lifesciences, disposed of 271 shares of common stock on May 11, 2025, to cover tax obligations.
Summary
- On May 11, 2025, Daniel J. Lippis, CVP of JAPAC at Edwards Lifesciences, disposed of 271 shares of common stock.
- The transaction was executed at a price of $73.68 per share.
- This disposal was related to covering tax obligations.
- Following the transaction, Lippis directly owns 26,345.1066 shares of Edwards Lifesciences common stock.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing detailing a stock disposal for tax purposes. It doesn't indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction appears to be a standard tax-related stock disposal, which is common among executives.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 05/11/2025 | Date of stock disposal transaction |
| 05/12/2025 | Date of signature by Attorney-in-Fact |
Keywords
Form 4, Edwards Lifesciences, Stock Disposal, Beneficial Ownership, Daniel J. Lippis, JAPAC, Executive Compensation, Tax Obligations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.